By Connor Hart
Geron has launched a search for a new chief executive, as John Scarlett plans to step down from the company's top role, effective March 31.
At that time, Scarlett will additionally step down from his roles as president and chairman of the board, the biopharmaceutical company said Tuesday.
While Geron searches for a permanent replacement, the company has appointed board member Dawn Carter Bir as interim president and chief executive. It additionally named Elizabeth O'Farrell as board chair.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 11, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.